$169.99 inc. GST
Retatrutide (LY3437943) is a next-generation tri-agonist research peptide targeting the GLP-1, GIP and glucagon receptors.
It is widely studied in metabolic research for its role in appetite regulation, energy expenditure, glucose metabolism and body composition. Each vial contains 10mg of research-grade lyophilised Retatrutide, independently tested in Australia for purity using HPLC and mass spectrometry before dispatch.
Fast Australian shipping
Discreet packaging
Australian Tested
For laboratory research use only. Not for human consumption.